Clinical trials underestimate the age of chronic myeloid leukemia (CML) patients. Incidence and median age of Ph/BCR-ABL-positive CML and other chronic myeloproliferative disorders in a representative area in Germany

Leukemia. 2009 Mar;23(3):602-4. doi: 10.1038/leu.2008.245. Epub 2008 Sep 11.

Authors

M Rohrbacher, U Berger, A Hochhaus, G Metzgeroth, K Adam, T Lahaye, S Saussele, M C Müller, J Hasford, H Heimpel, R Hehlmann

PMID: 18784744
DOI: 10.1038/leu.2008.245

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Adolescent
Adult
Age Distribution*
Aged
Aged, 80 and over
Cancer Care Facilities / statistics & numerical data
Clinical Trials as Topic / statistics & numerical data*
Female
Germany / epidemiology
Hospitals, Community / statistics & numerical data
Hospitals, Pediatric / statistics & numerical data
Hospitals, University / statistics & numerical data
Humans
Incidence
Leukemia, Myelogenous, Chronic, BCR-ABL Positive / epidemiology*
Male
Middle Aged
Myeloproliferative Disorders / epidemiology*
Private Practice / statistics & numerical data
Young Adult